Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
McKesson
Medtronic
Express Scripts

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lesogaberan

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Lesogaberan?

Lesogaberan is an investigational drug.

There have been 8 clinical trials for Lesogaberan. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2007.

The most common disease conditions in clinical trials are Gastroesophageal Reflux, Heartburn, and Renal Insufficiency. The leading clinical trial sponsors are AstraZeneca, National Taiwan University Hospital, and Ministry of Science and Technology, Taiwan.

Recent Clinical Trials for Lesogaberan
TitleSponsorPhase
Lesogaberan in Chinese Patients With Refractory Reflux SymptomsMinistry of Science and Technology, TaiwanPhase 2
Lesogaberan in Chinese Patients With Refractory Reflux SymptomsNational Taiwan University HospitalPhase 2
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPIAstraZenecaPhase 2

See all Lesogaberan clinical trials

Clinical Trial Summary for Lesogaberan

Top disease conditions for Lesogaberan
Top clinical trial sponsors for Lesogaberan

See all Lesogaberan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Merck
Boehringer Ingelheim
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.